Immunotherapy News and Research

Latest Immunotherapy News and Research

Canadian and Israeli researchers join forces for new research program

The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between the Azrieli Foundation, Canada's International Development Research Centre, the Canadian Institutes of Health Research, and the Israel Science Foundation that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine.

30 Oct 2017

Cancer researchers make breakthrough in identifying genetic changes during immunotherapy

For some cancer patients, the road to remission and healing can have its share of speed bumps. That's particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which initially was effective against their tumors.

28 Oct 2017

Allergists look for ways to improve ‘webside manner’

How does an allergist communicate effectively with his or her patient when they're not in the same room with the person being examined? The issue of improving "webside" manner – is one topic in a panel discussion on telemedicine during the American College of Allergy, Asthma and Immunology Annual Scientific Meeting.

27 Oct 2017

Dogs may protect children from allergic eczema and asthma

"Good dog!" Two studies being presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting show there may be even more reason to love your dog.

27 Oct 2017

Research: Peanut allergy in children has increased 21% since 2010

Parents often worry about peanut allergies because the reaction to peanuts can be very severe. New, late-breaking research being presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting suggests that peanut allergy in children has increased 21 percent since 2010, and that nearly 2.5 percent of U.S. children may have an allergy to peanuts.

27 Oct 2017

Research: 45% of adults with food allergies develop them in adulthood

When people think of food allergies, it's mostly in relation to children. New research being presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting shows that almost half of all food-allergic adults surveyed reported one or more adult-onset food allergies.

27 Oct 2017

New targeted therapies help relieve symptoms of atopic dermatitis

If you think only infants suffer from eczema, think again. The uncomfortable, itchy rash that most people relate to babies and young children occurs frequently in adults.

27 Oct 2017

Eczema and family history linked to severe hospitalization for children with asthma

Asthma and allergies are related, and many people who suffer from asthma have allergies that trigger their asthma. Research being presented at the American College of Allergy, Asthma and Immunology's Annual Scientific Meeting examines the relationship between medical history and allergic reactions in children, and how long they stayed in the hospital after an asthma attack.

27 Oct 2017

Study: Most pediatricians do not tell parents about early peanut introduction to prevent allergy

Guidelines to help parents introduce peanut-containing products to infants to prevent peanut allergies aren't being discussed. New research presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting shows pediatricians are not only not having the discussion, they're not referring high-risk babies for testing prior to peanut introduction.

27 Oct 2017

Sleeper cells in cancerous tumors can be destroyed if they possess specific defects

In many metastasized types of cancer, disseminated tumors grow back despite successful chemotherapy. As a research team under the direction of the University of Bern, Switzerland, has now discovered, this is because of isolated cancer cells that survive the chemotherapy due to a phase of dormancy.

27 Oct 2017

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

Vanderbilt-Ingram Cancer Center has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR T) therapy for treatment of adult patients with a specific type of lymphoma.

25 Oct 2017

Direct application of immune cells accelerates healing of acute, chronic wounds in mice

A Massachusetts General Hospital research team has found a surprising potential solution to a persistent clinical problem - the healing of chronic wounds. In their report published in Wound Repair and Regeneration, the investigators from the MGH Vaccine and Immunotherapy Center describe how application of mature B lymphocytes - the immune cells best known for producing antibodies - greatly accelerated the healing of acute and chronic wounds in both diabetic and nondiabetic mice.

25 Oct 2017

Researchers develop new way to genetically engineer T cells for treating leukemia relapse

Researchers at Fred Hutchinson Cancer Research Center and the University of Washington have developed a novel way to genetically engineer T cells that may be effective for treating and preventing leukemia relapse.

25 Oct 2017

Fight CRC and CRI announce publication of ‘A Blueprint to Advance Colorectal Cancer Immunotherapies’

Fight Colorectal Cancer and the Cancer Research Institute, are proud to announce "A Blueprint to Advance Colorectal Cancer Immunotherapies" will be published in the November 2017 issue of the journal Cancer Immunology Research (published online ahead of print on October 16, 2017).

24 Oct 2017

New vaccine for pneumonia holds promise to save thousands of lives

In 2004, pneumonia killed more than 2 million children worldwide, according to the World Health Organization. By 2015, the number was less than 1 million.

20 Oct 2017

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

Following a successful clinical trial involving Dana-Farber Cancer Institute and Brigham and Women's Hospital, the first chimeric antigen receptor (CAR) T-cell therapy for adult cancers was approved by the Food and Drug Administration today.

20 Oct 2017

Gene circuit can be used to switch on inside cancer cells and stimulate immune attack, study suggests

A new study, conducted by researchers at MIT, suggests that a recently developed synthetic gene circuit can stimulate the immune system to kill cancer cells when it identifies indications of the cancer. The gene circuit will only stimulate a therapeutic response when it identifies two particular cancer markers.

20 Oct 2017

New CAR-T cell therapy offers effective option for certain blood cancer patients

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers.

19 Oct 2017

Scientists receive critical funding to study treatments for three deadly cancers

Immunotherapy for leukemia patients has been nothing short of a miracle. Now scientists hope to use that science and other forms of gene therapy to tackle three of the deadliest forms of cancer: glioblastoma (brain cancer), sarcoma (bone cancer) and ovarian cancer.

17 Oct 2017

Synthetic compound targets enzyme that supports survival and dissemination of metastatic cells

Cancer can most often be successfully treated when confined to one organ. But a greater challenge lies in treating cancer that has metastasized, or spread, from the primary tumor throughout the patient's body.

17 Oct 2017

Immunotherapy News and Research

Latest Immunotherapy News and Research

Canadian and Israeli researchers join forces for new research program

Cancer researchers make breakthrough in identifying genetic changes during immunotherapy

Allergists look for ways to improve ‘webside manner’

Dogs may protect children from allergic eczema and asthma

Research: Peanut allergy in children has increased 21% since 2010

Research: 45% of adults with food allergies develop them in adulthood

New targeted therapies help relieve symptoms of atopic dermatitis

Eczema and family history linked to severe hospitalization for children with asthma

Study: Most pediatricians do not tell parents about early peanut introduction to prevent allergy

Sleeper cells in cancerous tumors can be destroyed if they possess specific defects

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

Direct application of immune cells accelerates healing of acute, chronic wounds in mice

Researchers develop new way to genetically engineer T cells for treating leukemia relapse

Fight CRC and CRI announce publication of ‘A Blueprint to Advance Colorectal Cancer Immunotherapies’

New vaccine for pneumonia holds promise to save thousands of lives

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

Gene circuit can be used to switch on inside cancer cells and stimulate immune attack, study suggests

New CAR-T cell therapy offers effective option for certain blood cancer patients

Scientists receive critical funding to study treatments for three deadly cancers

Synthetic compound targets enzyme that supports survival and dissemination of metastatic cells

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Immunotherapy News and Research

Latest Immunotherapy News and Research

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in